Mikkiya
Phone:+86 18215437034(whatsapp)
Email:shengzhikai2@shengzhikai.com.cn
Address: 903, block B, Fortune Plaza, Luyang District, Hefei City, Anhui Province
Product name Sermaglutide
CAS number 910463-68-2
Molecular formula C187H291N45O59
Molecular weight 4113.57754
Appearance White powder
Purity 99.0%
Function Semaglutide can reduces hunger, food craving and body fat.
Discribe Semaglutide is a new generation GLP-1 (glucagon-like peptide-1) analogues. Semaglutide is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes mellitus. Compared with lilarlutide, somalutide has a longer aliphobic chain and an increased hydrophobicity, but somalutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced.PEG modification can not only tightly bind to albumin, cover up the DPP-4 enzymatic hydrolysis site, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.
Semaglutide (USAN; trade name Ozempic) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Ozempic. As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production. It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed in 2016. FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour. It can be used as both injection-type or oral-type drug.
Researchers at the University of Leeds reported in 2017 that it can also be used for the treatment of obesity. It reduces hunger, food craving and body fat.
Packing and Delievery
Liquid 1L / Bottle, 25L/drum (5L, 10L all available)
Powder 1kg/ plastic bag, 25KG/drum (5kg, 10kg all available)
Basically, our product MOQ is 1KG/1L for testing.